Valuation: Oscotec Inc.

Market Cap 1,373B 1.04B 929M 858M 778M 1.45B 98.33B 1.47B 10.29B 4.08B 51.54B 3.89B 3.8B 163B P/E 2026 *
42.7x
P/E 2027 * 11.5x
Enterprise Value 1.19B 896K 804K 742K 673K 1.26M 85.09M 1.27M 8.9M 3.53M 44.6M 3.36M 3.29M 141M EV / Sales 2026 *
14.1x
EV / Sales 2027 * 5.57x
Free-Float
72.01%
Yield 2026 *
-
Yield 2027 * -
1 day-0.28%
1 week-6.27%
Current month+0.70%
1 month+0.28%
3 months+15.62%
6 months-29.47%
Current year-20.58%
1 week 35,700
Extreme 35700
39,500
1 month 34,150
Extreme 34150
40,850
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 64 26/03/2020
Corporate Officer/Principal 54 01/09/1999
Comptroller/Controller/Auditor 71 30/03/2023
Director TitleAgeSince
Director/Board Member 54 01/09/1999
Director/Board Member 64 26/03/2020
Director/Board Member 66 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
7/24/25 A Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-6.27%-5.28%+88.65% 1.04B
+0.22%+3.35%+55.30%+125.65% 1,140B
+0.91%+5.89%+41.14%+80.36% 641B
-0.12%+1.31%+25.62%+97.24% 507B
+0.63%+4.97%+47.12%+68.18% 383B
+0.86%-1.26%+62.10%+34.36% 347B
+1.02%+3.69%+23.73%+51.35% 293B
-0.25%+3.40%+2.31%+23.38% 266B
+0.75%+5.41%+53.53%+66.09% 240B
+0.25%+3.93%+31.54%+102.65% 197B
Average +0.54%+2.13%+33.71%+73.79% 401.48B
Weighted average by Cap. +0.61%+2.98%+42.00%+84.56%

Financials

2026 *2027 *
Net sales 84B 63.31M 56.82M 52.47M 47.58M 88.93M 6.01B 90.02M 629M 250M 3.15B 238M 233M 10B 192B 145M 130M 120M 109M 203M 13.75B 206M 1.44B 571M 7.2B 543M 532M 22.85B
Net income 32B 24.12M 21.65M 19.99M 18.13M 33.88M 2.29B 34.29M 240M 95.17M 1.2B 90.54M 88.6M 3.81B 119B 89.69M 80.5M 74.33M 67.4M 126M 8.52B 128M 891M 354M 4.47B 337M 329M 14.16B
Net Debt -185B -139M -125M -116M -105M -196M -13.24B -198M -1.39B -550M -6.94B -523M -512M -22.01B -304B -229M -206M -190M -172M -322M -21.76B -326M -2.28B -904M -11.41B -860M -842M -36.18B
Projected Income Statement - Annual - Oscotec Inc.
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
57
Date Price Change Volume
27/10/26 ₩35,900.00 -0.28% 123,683
26/10/26 ₩36,000.00 -3.36% 61,600
23/10/26 ₩37,250.00 -0.67% 96,040
22/10/26 ₩37,500.00 -0.79% 106,635
21/10/26 ₩37,800.00 +0.80% 124,745
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
MarketScreener Ratings - Oscotec Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35,900.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+108.91%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Oscotec Inc.
  1. Stock Market
  2. Stocks
  3. A039200 Stock